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Abstract
Background: Comorbidity of Autism Spectrum Disorders with seizures or abnormal EEG (Autism-Epilepsy Phenotype)
suggests shared pathomechanisms, and might be a starting point to identify distinct populations within the clinical
complexity of the autistic spectrum. In this study, we tried to assess whether distinct subgroups, having distinctive clinical
hallmarks, emerge from this comorbid condition.
Methods: Two-hundred and six individuals with idiopathic Autism Spectrum Disorders were subgrouped into three
experimental classes depending on the presence of seizures and EEG abnormalities. Neurobehavioral, electroclinical and
auxological parameters were investigated to identify differences among groups and features which increase the risk of
seizures. Our statistical analyses used ANOVA, post-hoc multiple comparisons, and the Chi-squared test to analyze
continuous and categorical variables. A correspondence analysis was also used to decompose significant Chi-squared and
reduce variables dimensions.
Results: The high percentage of children with seizures (28.2% of our whole cohort) and EEG abnormalities (64.1%)
confirmed that the prevalence of epilepsy in Autism Spectrum Disorders exceeds that of the general population. Seizures
were associated with severe intellectual disability, and not with autism severity. Interestingly, tall stature (without
macrocephaly) was significantly associated with EEG abnormalities or later onset seizures. However, isolated macrocephaly
was equally distributed among groups or associated with early onset seizures when accompanied by tall stature.
Conclusions: Tall stature seems to be a phenotypic ‘‘biomarker’’ of susceptibility to EEG abnormalities or late epilepsy in
Autism Spectrum Disorders and, when concurring with macrocephaly, predisposes to early onset seizures. Growth pattern
might act as an endophenotypic marker in Autism-Epilepsy comorbidity, delineating distinct pathophysiological subtypes
and addressing personalized diagnostic work-up and therapeutic approaches.
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Introduction
Autism spectrum disorders (ASD) are characterized by a wide
range of dysfunctions in communicative and social ability, and by
repetitive, restricted, and stereotyped interests and behaviors.
However, clinical presentation of ASD is extremely heteroge-
neous, reflecting different degrees of severity and perhaps multiple
pathogenetic backgrounds. Children with ASD have a higher risk
of developing seizures (5–46%) [1] when compared to the general
population (0.5–1%), and up to one in three subjects with ASD
displays electroencephalographic (EEG) abnormalities without
seizures [2]. These findings suggest that, in some patients, ASD,
epilepsy and EEG abnormalities may share common genetic
causes or, possibly, pathophysiological mechanisms [3,4–6], and
that this comorbidity - termed Autism-Epilepsy Phenotype (AEP)
[3,7,8] - deserves further investigation. The complexity of AEP,
however, which possibly reflects multifaceted pathomechanisms
causing this comorbid condition, makes it difficult to ascertain the
actual relationships [4,9,10].
Over the past few years, a number of studies have assessed the
comorbidity of ASD and epilepsy [1] by analyzing features such as
time of seizures onset (infantile versus pubertal) [3,11,12], presence
of developmental regression [13–17], macrocephaly [18], or motor
problems [19] without reaching a unifying mechanism or
conclusive results. A recent meta-analysis has suggested that
intellectual disability and female gender represent significant risk
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factors for the development of seizures in ASD [20]. Moreover, a
latent class cluster analysis has defined a distinct subgroup of ASD
showing epilepsy, early diagnosis, and distinctive neurobehavioral
features [9]. Nonetheless, the link between ASD and epilepsy
remains largely elusive, probably because of the heterogeneity of
samples which included, in most studies, children with ‘‘non
idiopathic’’ ASD or symptomatic seizures, or even lacking a formal
diagnosis of epilepsy.
In this study, we attempted a more detailed analysis of the
phenotypic features of children with ASD, with and without
epilepsy/EEG abnormalities, to pinpoint distinctive characteristics
associated with this comorbid condition. Measures of cognitive
and socio-behavioral symptoms, as well as electro-clinical features
and auxological parameters, alone or in combination, were
investigated to explore specific phenotypic traits associated with
risk of seizures (or EEG abnormalities) in ASD, and to foster the
clustering of affected individuals.
Materials and Methods
Ethics Statement
This study was approved by the Research Ethics Committee of
the IRCCS Fondazione Stella Maris, Pisa (Italy). All patients or
their parents signed an informed consent prior to the assessment,
and agreed for their medical data to be used anonymously in
future research.
Participants
We collected and reviewed the clinical data of 206 individuals
with ASD who underwent EEG recordings in consecutive
hospitalizations between January 2010 and September 2012 in a
third-level center for ASD diagnosis. All subjects had received a
clinical, neurobehavioral assessment and EEG evaluation as part
of a routine diagnostic work-up. Individuals with a past history of
seizures or abnormal EEG also received expert advice for epilepsy.
The sample consisted of 174 boys (M) (84.5%) and 32 girls (F)
(15.5%) (M:F= 5:1), aged 2.2 to 20.8 years (yrs) (mean age 7.1;
standard deviation (SD) 3.8). The sample was divided into 3
subgroups: 1. ASD with a history of seizures (ASD-seizures); 2.
ASD with EEG abnormalities, but without seizures (ASD-EEG); 3.
ASD without seizures and with normal EEG (ASD ‘‘simplex’’)
(Table 1). We defined as ‘‘EEG abnormalities’’ focal or diffuse
spikes, sharp waves, and/or spike and wave complexes, and/or
focal slowing.
All clinical and neurophysiologic data were collected on a
dedicated database. Patients with non-idiopathic autism and\or
symptomatic epilepsy, due to congenital or acquired cerebral
lesions or known genetic syndromes, were excluded. Brain MRI
was performed in 132/206 patients: almost all of the cases in the
ASD-seizures group (53/58; 91.4%), and about half of the children
in the remaining two groups (46/76 (60.5%) in the ASD-EEG and
33/72 (45.8%) in the ASD ‘‘simplex’’ group). High-resolution
karyotype and Fragile-X testing were performed in 192/206
(93.2%) and 190/206 (92.2%) patients, respectively.
Methods
The diagnosis of ASD was performed according to the criteria
of the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition, Text Revision (DSM-IV TR) for Pervasive
Developmental Disorders, and confirmed in 154/206 (74.8%)
children with the gold standard Autism Diagnostic Observation
Schedule- Generic (ADOS-G) administered by a psychologist
(certified for clinical and research practice).
Video-EEG-polygraphic recordings while awake and asleep
were digitally acquired, positioning electrodes on the scalp
according to the 10–20 system, and visually inspected by two
independent investigators. When EEG evaluations were discor-
dant, a third opinion by a clinical expert was requested. Seizures
and epilepsy phenotypes were classified according to the
International League Against Epilepsy (ILAE) classifications
(1981, 1989) and the subsequent Report of the ILAE Commission
on Classification and Terminology (2005–2009) [21].
Auxological parameters were obtained as part of the standard-
ized clinical examination and, when possible, retrieved by
reviewing previous clinical data from primary-care pediatricians.
Height (H) and weight (W) were measured by calibrated scales.
Head circumference (HC) was obtained by placing a plastic, non-
stretchable tape measure over the maximum occipital-frontal
circumference. For reference, height measurements were convert-
ed to z-scores for age (standard deviation score, SDS) using the
‘‘SIEDP Growth Calculator’’ based on the Cacciari and colleagues
growth charts for the Italian population from 2 to 20 yrs [22]. The
values of W and HC were plotted on standard growth charts
[22,23]. Weight was not included in the statistical analyses because
this parameter could be affected by aberrant eating behaviors, and
therefore deemed to be less reliable and difficult to correlate with
other features.
Cognitive development was assessed using the following
standardized tools: Griffiths Mental Development Scale Extend-
ed-Revised (GMDS-ER), Leiter International Performance Scale-
Revised (LIPS-R), Wechsler Preschool and Primary School
Intelligence Scale-III (WPPSI), and Wechsler Intelligence Scale
for Children-III (WISC-III). When standardized evaluation was
not applicable, the cognitive level was assessed through clinical
observation. We considered three categories for statistical analyses,
based on the IQ score (when available) and the clinician’s
judgment: normal-to-borderline level, mild-to-moderate delay,
and severe delay. Language development was assessed through
clinical observation and classified as absent, delayed, and normal.
Parents were asked to fill the Child Behavior Checklist (CBCL
1K-5 or CBCL 6-18), a parent-report questionnaire measuring
child behavioral problems. The following features were also
annotated, at first examination and during the time of clinical
observation, and labeled as present or absent: developmental
regression, sleep problems, regulation disorders of sensory
processing (hypersensitive, hyposensitive, sensory stimulation-
seeking), frustration intolerance, self-injurious behavior or aggres-
siveness and stereotypes. Whenever possible, family history for
epilepsy, febrile seizures, ASD, anxiety, mood disorders, psychotic
disorders, cognitive and language delay was also investigated up to
the 4th degree of kinship and carefully annotated.
Statistical Analysis
We adopted the IBM SPSS software version 16 for our
statistical analysis. For continuous variables, we performed t-test,
analyses of variance (ANOVA) and post-hoc multiple comparisons
using the Bonferroni correction or Dunnet test in accordance with
the Levene test on variance homogeneity. The option ‘‘exclude
cases analysis by analysis’’ was chosen to manage missing data. To
analyze categorical variables, we used the Chi-squared test and the
correspondence analysis (CA) to decompose the significant Chi-
squared and reduce variables dimensions. CA is a multivariate
technique specifically designed to capture non linear associations
between variables, when a ‘‘model-free’’ approach rather than an
a priori assumption on the possible type of association is chosen. Its
graphical display shows how levels from two or more categorical
variables cluster together, allowing an overview of the salient
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relationships among them. Statistically significant data are
indicated by asterisks in the tables. Significance was set at
p#0.010.
Results
The three experimental groups were not significantly different
with respect to sample size, gender, and ASD diagnosis (Table 1).
We found a mild association between female gender and ASD-
EEG group which was, however, below the cut-off for statistical
significance (p = 0.044). EEG abnormalities were found in 132/
206 subjects (64.1%), including almost all of the children with
seizures (56/58) and about half (76/148) of those without seizures
(Fisher’s Exact test, p,0.001; Table 1). Seizures were reported in
58/206 patients (28.2% of the whole sample), and in 56/132
(42.4%) children with EEG abnormalities. The age at time of
clinical evaluation was significantly higher (p, 0.001) in the ASD-
seizures group compared to the other two experimental groups
(Table 1), probably due to the presence of individuals with
adolescence-onset epilepsy in our sample. Onset of seizures in
ASD, indeed, has a bimodal distribution, with one peak occurring
before the age of 5 years, and a later onset after age 10 [3,7,8].
Family data and neurobehavioral features
A family history for psychiatric diseases (ASD, anxiety, mood
disorders, psychosis) or cognitive and language delay was equally
observed in the three experimental groups (Table S1 in
Supporting Information S1), whereas epilepsy and febrile seizures
were more common (showing a trend to significance) in relatives of
children belonging to the ASD-seizures group (Table 2).
Clinical and behavioral features, assessed by the ADOS-G and
CBCL scores, showed no significant differences between groups
(Table S2 in Supporting Information S1). Behavioral features
recorded in the clinical interviews by checking the presence/
absence of sleep disorders, frustration intolerance, self/hetero
injurious behavior, regulation disorders of sensory processing, and
stereotyped behaviors did not differ between groups (Table S3 in
Supporting Information S1).
Regressive onset, cognitive and language development
There were no significant differences between groups with
respect to the onset (regressive versus non-regressive) of ASD
(Table 2).
Standardized cognitive evaluation was obtained in 155/206
individuals, whereas 35 individuals were only evaluated through
expert clinical observations. Cognitive information was not
available in 16 individuals. Chi-squared and CA analyses revealed
that severe delay was statistically associated (p = 0.010) with the
ASD-seizures group on dimension 1 (Table 2 and Figure 1; for
details see Table S4 in Supporting Information S1). No significant
differences were found with respect to gender. Assessment of
language development revealed no significant differences across
groups (Table 2).
Auxological parameters
We obtained complete auxological data in 187/206 individuals.
The age (in years) at time of auxological measures ranged from 2.0
to 20.7, with a mean age of 7.1 (SD 3.7) for H, 6.9 (3.6) for W and
6.6 (3.6) for HC. The distribution of Z-scores for height (Zh) in the
whole sample showed a normal shape (Kolmogorov-Smirnov,
p = 0.036; Shapiro, p = 0.101), with significant rightward shift with
respect to the normative distribution (mean: 0.29; SD: 1.21;
t = 3.32, df = 189, p = 0.001; Figure 2A). By separately testing the
Zh distributions of the three experimental groups, we found that
ASD ‘‘simplex’’ did not differ from the normative distribution
(mean: 0.07; SD: 1.06; t = 0.508, df = 65, p = 0.613, Figure 2B).
Conversely, there was a significant rightward shifted Zh distribu-
tion (mean: 0.41; SD: 1.26; t = 2.727, df = 69, p = 0.008, Figure
Table 1. Characteristics of total sample and experimental groups.
Total sample Experimental Groups
ASD-seizures ASD-EEG ASD ‘‘simplex’’ Effect size Test p
Sample size 206 58 (28.2%) 76 (36.9%) 72 (35%) - x2 = 2.602 0.270
Age assessment
(yrs)*
mean6sd 7.163.8 9.464.9 6.663 5.762.6 g=0.398 F = 19.093 ,0.001*
range 2.2–20.8 2.2–20.8 2.4–17.5 2.2–15.1
C.I. (95%) 6.5–7.5 8.1–10.7 5.8–7.3 5.1–6.3
Gender
Boys 174 (84.5%) 51 (29.3%) 58 (33.3%) 65 (37.4%) Wc = 0.174 x2 = 6.232 0.044
Girls 32 (15.5%) 7 (21.9%) 18 (56.2%) 7 (21.9%)
ASD Diagnosis
Autism 73 (35.4%) 22 (30.1%) 24 (32.9%) 27 (37%) Wc = 0.096 x2 = 3.767 0.430
PDD-NOS 130 (63.1%) 34 (26.2%) 52 (40%) 44 (33.8%)
Asperger 3 (1.5%) 2 (66.7%) 0 (0%) 1 (33.3%)
EEG abnormalities**
Yes 132 (64.1%) 56 (42.4%) 76 (57.6%) - Fisher’s Exact Test ,0.001**
No 74 (35.9%) 2 (2.7%) - 72 (97.3%)
*one-way ANOVA, post-hoc Bonferroni method, ASD-seizures . ASD-EEG, p,0.001; ASD-seizures . ASD ‘‘simplex’’, p,0.001; ASD-EEG vs ASD ‘‘simplex’’, p.0.010;
**EEG abnormalities are significantly associated with the presence of seizures (56/58 children with seizures vs 76/148 without seizures).
Wc = Cramers’ phi coefficient, g= eta, x2 = the Pearson chi-squared test, F= F of Fisher, one-way ANOVA.
doi:10.1371/journal.pone.0075015.t001
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2C) in the ASD-EEG group and a trend towards a rightward shift
(mean: 0.41; SD: 1.29; t = 2.355, df = 53, p = 0.022, Figure 2D) in
the ASD-seizures group because of the presence of a high rate of
tall individuals in the upper boundary of the distributions. In
particular, 10/54 (18.5%) children in the ASD-seizures group, and
19/70 (27.1%) in the ASD-EEG group had height measures over
1.5 SDS (93rd percentile), which is considerably more than 7%
expected in the normative population (Figure 2C, 2D). On the
other hand, only 4/66 (6.1%) children in the ASD simplex group
were over the 93rd percentile which is similar to normative data in
the healthy population. To further explore this finding, we
considered height over 1.5 SDS as a categorical variable (tall
stature) and found that it was strongly unrelated to the ASD
‘‘simplex’’ group, whereas it was positively associated with the
ASD-EEG group, and weakly associated with the ASD-seizures
group (p = 0.005; Table 3, and Table S5 in Supporting
Information S1).
Macrocephaly (HC over the 97th percentile) was found in 53/
190 (27.9%) patients in the whole sample; however its occurrence
was not significantly different in the three groups (Table 3).
In order to better understand the relation between HC and H,
auxological features were decomposed and combined in a single
‘‘auxological variable’’ for each individual defining four major
categories: Aux1.Normal HC and H; Aux2.Macrocephaly com-
bined with normal stature (Isolated Macrocephaly); Aux3.Macro-
cephaly with tall stature; Aux4.Tall stature combined with normal
HC (Isolated Tall Stature). The distribution of each category in
the total sample and in the three experimental groups is
summarized in Table 3. CA on this ‘‘auxological variable’’ vs.
the experimental groups showed a two-dimensional solution (see
Table 3 and Figure 3). On dimension 1, the largest contribution to
inertia (80%) indicated a significant association between isolated
tall stature and EEG abnormalities (without seizures). On
dimension 2, concurrence of tall stature and macrocephaly was
Table 2. Family data, regressive onset, cognitive and language development.
Total sample Experimental Groups
ASD-seizures ASD-EEG ASD ‘‘simplex’’ Effect size Test p
Family History Epilepsy
Yes 41 (20.4%) 18 (43.9%) 9 (22%) 14 (34.1%) Wc = 0.207 x2 = 8.582 0.014
No 160 (79.6%) 37 (23.1%) 67 (41.9%) 56 (35%)
Family History Febrile
Seizures
Yes 21 (10.4%) 11 (52.4%) 5 (23.8%) 5 (23.8%) Wc = 0.192 x2 = 7.397 0.025
No 180 (89.6%) 44 (24.4%) 71 (39.4%) 65 (36.1%)
Regressive onset
Yes 82 (41.4%) 27 (32.9%) 34 (41.5%) 21 (25.6%) Wc = 0.173 x2 = 5.896 0.052
No 116 (58.6%) 28 (24.1%) 39 (33.6%) 49 (42.2%)
Level of Cognitive
Development*
Normal to Borderline 84 (44.2%) 15 (17.9%) 32 (38.1%) 37 (44%) Wc = 0.187 x2 = 13.347 0.010*
Mild to Moderate Delay 68 (35.8%) 21 (30.9%) 22 (32.4%) 25 (36.8%)
Severe Delay 38 (20%) 18 (47.4%) 13 (34.2%) 7 (18.4%)
Level of Language
Development
Normal 42 (20.4%) 13 (31%) 17 (40.5%) 12 (28.5%) Wc = 0.072 x2 = 2.121 0.714
Delayed 107 (51.9%) 27 (25.2%) 38 (35.5%) 42 (39.3%)
Absent 57 (27.7%) 18 (31.6%) 21 (36.8%) 18 (31.6%)
*Severe cognitive delay is associated with the ASD-seizures group (see Figure 1, and CA in Table S4 in Supporting Information S1).
Wc = Cramers’ phi coefficient, x2 = the Pearson chi-squared test.
doi:10.1371/journal.pone.0075015.t002
Figure 1. Biplot for cross-tabulation of Level of Cognitive
Development by Experimental Groups. Correspondence analysis
at two-dimensional solution showed that the ASD-seizures group is
relatively associated with severe cognitive delay (closed circle).
doi:10.1371/journal.pone.0075015.g001
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significantly associated with seizures. Isolated macrocephaly was
equally distributed among groups (Figure 3, and Table S6 in
Supporting Information S1).
Mean ages at latest clinical assessment were 7.6 (SD 4.0) years
(range 2.9–15.7) in the Aux3 category (tall stature and macro-
cephaly) and 7.0 (2.9) years (3.6–14.3) in the Aux4 category (tall
stature and normal HC) (t = 0.542, df = 31, p= 0.592) whereas
mean ages at seizure onset were 5.0 (3.0) years (0.7–9.2) in Aux3
and 12.5 (2.5) years (10.8–14.3) in Aux4 (t = 3.258, df = 8,
p = 0.012). The clear trend to significance suggested that children
with isolated tall stature had a delayed onset of seizures when
compared to tall, macrocephalic children.
Auxological categories did not differ with respect to all the other
variables mentioned in the Methods Section.
Discussion
In our cohort, rates of seizures (28.2%) and EEG abnormalities
(64.1%) are in line with the literature data confirming that the
prevalence of epilepsy in ASD noticeably exceeds that of the
general population (0.5–1%) [8,20]. EEG abnormalities were
Figure 2. Distribution of Z-scores for height (Zh). A. The histogram of Zh of whole sample shows a significant rightward shift (dashed curve)
compared to the normative distribution (closed curve). B. The Zh distribution of ASD ‘‘simplex’’ group shows no difference with respect to normative
distribution. C. The Zh distribution of ASD-EEG group shows a significant rightward shift (dashed curve) compared to the normative distribution
(closed curve). D. The Zh distribution of ASD-seizures group shows a trend towards a rightward shift (dashed curve) compared to the normative
distribution (closed curve). Arrows in C and D indicate a clearly higher rate of tall individuals over 1.5 SDS.
doi:10.1371/journal.pone.0075015.g002
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associated with seizures in 56/132 (42.4%) children, and severe
intellectual disability was also associated with increased risk of
seizures (p = 0.010), confirming previous findings [20,24], though
we did not observe the association of seizures with gender.
However, the cognitive profile in our cohort was similar in boys
and girls and it has been suggested that girls with ASD may have a
higher risk of epilepsy because of a more severe degree of
intellectual disability [20] (D. Cohen, personal communication,
December 17, 2012). The trend to a significant association
between female gender and ASD-EEG group (p = 0.044), howev-
er, suggests that this possible relationship should be further
investigated in larger samples. Interestingly, we also found a higher
than expected occurrence of epilepsy and/or febrile seizures in
relatives of the ASD-seizures group, suggesting that a family
history for seizures represents a risk factor for developing epilepsy
in ASD. Like other features of AEP the susceptibility to seizures
may be a single part, inherited from less penetrant or non-affected
parents, of a more complex disorder and contributes, through
interaction with multiple genetic and environmental factors, to the
overt phenotype. Alternatively, the phenotype may be caused by de
novo mutations in developmental genes [25,26]. ADOS scores did
not differ between groups in our sample suggesting that seizures
(or EEG abnormalities) do not affect per se the core behavioral,
communicative and social features of ASD.
The most relevant finding of the present work was that seizures
and EEG abnormalities were significantly related to somatic
growth patterns. The rates of children with stature over 1.5 SDS
(17.4%) and with macrocephaly (27,9%) in our sample were
considerably higher than expected in the general population,
suggesting that overgrowth in ASD may involve the whole body
and not be limited to the brain [27]. There is conflicting literature
about macrocephaly in ASD, in part due to different methodo-
logical approaches, such as the time point of head measurements,
and size of the samples investigated. While some authors do not
find significant differences between ASD and healthy children
[28,29], others report rates of macrocephaly ranging from 17 to
53% [30–32], and in line with our data. Recent findings indicate
that cranial overgrowth in ASD appears in the first year of life,
suggesting that a variety of mechanisms accelerating brain growth
in early development could predispose to autism [30,31,33–36].
However, specific processes responsible for early brain overgrowth
in ASD have not been identified. Even less clear are the issues
related to the prevalence and significance of other growth
parameters such as W and H in ASD. Recent studies have
focused on the different prevalence of tall stature in ASD
compared to healthy infants, emphasizing an overall disturbance
of somatic growth regulation, rather than a specific dysregulation
of neural development [27,33,37]. This observation also suggests
Table 3. Auxological parameters.
Total sample Experimental Groups
ASD-seizures ASD-EEG ASD ‘‘simplex’’ Effect size Test p
Tall Stature (.1.5 SDS)*
Yes 33 (17.4%) 10 (30.3%) 19 (57.6%) 4 (12.1%) Wc = 0.236 x2= 10.590 0.005*
No 157 (82.6%) 44 (28%) 51 (32.5%) 62 (39.5%)
Macrocephaly
Yes 53 (27.9%) 18 (34%) 21 (39.6%) 14 (26.4%) Wc = 0.120 x2= 2.756 0.252
No 137 (72.1%) 35 (25.5%) 49 (35.8%) 53 (38.7%)
Auxological Category**
AUX1 119 (63.6%) 33 (27.7%) 36 (30.3%) 50 (42%) Wc = 0.333 x2= 20.680 0.002**
AUX2 35 (18.7%) 10 (28.6%) 14 (40%) 11 (31.4%)
AUX3 17 (9.1%) 8 (47.1%) 6 (35.3%) 3 (17.6%)
AUX4 16 (8.6%) 2 (12.5%) 13 (81.2%) 1 (6.2%)
AUX1: Normal head circumference and height; AUX2: Isolated Macrocephaly; AUX3: Macrocephaly and Tall Stature; AUX4: Isolated Tall Stature.
*Tall Stature is strongly unrelated to the ASD ‘‘simplex’’ group, and is associated with the ASD-EEG group (see CA in Table S5 in Supporting Information S1). **Isolated
Tall Stature (AUX4) is associated with EEG abnormalities; concurrence of Tall Stature and Macrocephaly (AUX3) is associated to seizures; Isolated Macrocephaly (AUX 2) is
equally distributed among groups (see CA in Table S6 in Supporting Information S1).
Wc = Cramers’ phi coefficient, x2= the Pearson chi-squared test.
doi:10.1371/journal.pone.0075015.t003
Figure 3. Biplot for Cross-Tabulation of Auxological Categories
by Experimental Groups. Correspondence analysis at two-dimen-
sional solution showed that ASD-EEG group is relatively associated with
Isolated Tall Stature (AUX4, closed circle), and ASD-seizures group is
relatively associated with combined macrocephaly and tall stature
(AUX3, dashed circle).
doi:10.1371/journal.pone.0075015.g003
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that generalized overgrowth might represent a ‘‘biomarker’’
associated with one or more homogeneous clinical and patho-
physiological subtypes of ASD [33]. However, the relationship
between somatic growth and seizures (or EEG abnormalities) in
ASD has not been fully investigated and deserves further research.
We found that tall stature (without macrocephaly) was significantly
associated with EEG abnormalities without seizures, whereas
concurrence of tall stature and macrocephaly was significantly
associated with the overt autism-seizures phenotype. Only 2/16
children with isolated tall stature exhibited seizures, at age 10.8
and 14.3, respectively. Onset of seizures in ASD has a bimodal
distribution, with one peak occurring before the age of 5, and a
later onset after age 10 [3,7,8]. Indeed, the presence of individuals
with adolescence-onset epilepsy in our sample may explain the
higher mean age of the ASD-seizures patients compared to the
other two experimental groups. Although patients in the Aux3 and
Aux4 groups were assessed at a comparable age, children with
macrocephaly and tall stature (Aux3) had an earlier onset of
seizures (age 5 at the first peak for seizures), compared to children
with isolated tall stature (Aux4) who displayed later seizures at a
mean age of 12.5; the statistical analysis of the age at seizure onset
in the two groups showed a strong trend to significance (p = 0.012).
We may infer, indeed, that most children in the Aux4 group, at the
time of assessment, might not have displayed seizures as yet,
because too young in relation to mean age for onset of seizures in
that group, indicating the need to further confirm this finding
through a longitudinal follow-up. Therefore, while the combina-
tion of macrocephaly and tall stature seems to point out the
possibility of early seizures in ASD, isolated tall stature might
signal a ‘‘red flag’’ for monitoring EEG abnormalities, or the risk
of manifesting seizures in early teens or adolescence, although the
small number of patients having seizures in the Aux4 group (only
two subjects) limits that conclusion.
Isolated macrocephaly was equally distributed among our
groups, suggesting that brain overgrowth is not a factor directly
affecting the risk of seizures in ASD. This finding could be
interpreted under two possible scenarios. It is possible that the
different patterns of exaggerated growth (isolated tall stature,
isolated macrocephaly, tall stature plus macrocephaly) define
distinct latent genetic and pathophysiological variables (or
disorders) with diverse clinical and developmental features. A
more attractive alternative is that isolated tall stature and global
overgrowth are equally pieces of the same puzzling biological
process. This could result from the interwork of largely unknown
factors affecting both skeletal and brain growth and development.
As paroxysmal EEG and seizures are considered part of a
spectrum, which in different degrees denotes a similar neurobio-
logical disorder underlain by abnormal neuronal excitability, it is
tempting to hypothesize that the concurrence of tall stature and
macrocephaly may represent the extreme effect of polygenic
factors that affect not only the core behaviors of ASD but also
susceptibility and precocity in manifesting seizures.
In conclusion, this study suggests that tall stature is a possible
‘‘biomarker’’ of susceptibility to EEG abnormalities or late
epilepsy in ASD and, when concurring with macrocephaly,
predisposes to early onset seizures. We propose that the
identification of endophenotypic markers might help disclose
distinct pathophysiological and genetic mechanisms in ASD and
assist in clinical dissection, diagnostic work-up, and rational follow-
up in AEP.
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